- and in
general can be
avoided with the use of
synthetic heparins. Not all
patients with
heparin antibodies will
develop thrombocytopenia. Also, a benign...
- (December 2007). "Intravenous low-molecular-weight
heparins compared with
unfractionated heparin in
percutaneous coronary intervention: quantitative...
- is
generally given subcutaneously.
Commonly used low
molecular weight heparins are enoxaparin, dalteparin,
nadroparin and tinzaparin. In HIT, the platelet...
-
Heparin mimicking polymers are
synthetic compounds that
possess similar characteristics to
heparin, that is it can be used
clinically as an anticoagulant...
- 2008
Chinese heparin adulteration,
refers to
heparin adulteration incidents that
occurred in the
United States of
America in 2008.
Pharmaceutical company...
- The
enzyme heparin lyase (EC 4.2.2.7)
catalyzes the
following process:
Eliminative cleavage of
polysaccharides containing (1→4)-linked D-glucuronate or...
- is an
antithrombotic and
belongs to the
group of low
molecular weight heparins (LMWH).
Bemiparin is used for the
prevention of
thromboembolism after surgery...
-
Several anticoagulants are available. Warfarin,
other coumarins, and
heparins have long been used.
Since the 2000s,
several agents have been introduced...
- low-molecular-weight
heparin (LMWH) or
unfractionated heparin, or
increasingly with
direct acting oral
anticoagulants (DOAC).
Those initially treated with
heparins can...
-
Heparin necrosis is a
cutaneous condition and
usually occurs between days 5 and 10 of
heparin therapy.
Warfarin necrosis List of
cutaneous conditions...
